Does Iron Cause Bacterial Infections in Patients with End Stage Renal Disease?
Overview
Authors
Affiliations
Anemia management using erythropoietin and intravenous iron supplementation has improved the lives of many patients with end stage renal disease (ESRD). However, because iron is an essential nutrient for microorganisms, it is plausible that iron supplementation may promote infection. This review examines the literature on the connection between iron and infection, with a focus on the relevance of these data to hemodialysis patients treated according to the National Kidney Foundation--Dialysis Outcomes Quality Initiative (NKF-DOQI) Guidelines for Anemia Management. The current evidence does not show a cause-and-effect relationship between intravenous iron administration and an increased susceptibility to infection in hemodialysis patients. Therefore, the author does not recommend changing current iron management practices in ESRD patients because of concern about infectious risk.
Hepcidin and HFE protein: Iron metabolism as a target for the anemia of chronic kidney disease.
Canavesi E, Alfieri C, Pelusi S, Valenti L World J Nephrol. 2013; 1(6):166-76.
PMID: 24175256 PMC: 3782218. DOI: 10.5527/wjn.v1.i6.166.
Infection risk with bolus versus maintenance iron supplementation in hemodialysis patients.
Brookhart M, Freburger J, Ellis A, Wang L, Winkelmayer W, Kshirsagar A J Am Soc Nephrol. 2013; 24(7):1151-8.
PMID: 23787911 PMC: 3699831. DOI: 10.1681/ASN.2012121164.